111 related articles for article (PubMed ID: 12438176)
1. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
Ann N Y Acad Sci; 2002 Oct; 971():533-5. PubMed ID: 12438176
[No Abstract] [Full Text] [Related]
2. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
J Hypertens; 2002 Jul; 20(7):1335-45. PubMed ID: 12131530
[TBL] [Abstract][Full Text] [Related]
3. Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin.
Mahata SK; Mahapatra NR; Mahata M; Wang TC; Kennedy BP; Ziegler MG; O'Connor DT
J Biol Chem; 2003 Aug; 278(34):32058-67. PubMed ID: 12799369
[TBL] [Abstract][Full Text] [Related]
4. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
Mahata SK; Mahata M; Wakade AR; O'Connor DT
Mol Endocrinol; 2000 Oct; 14(10):1525-35. PubMed ID: 11043569
[TBL] [Abstract][Full Text] [Related]
5. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
[TBL] [Abstract][Full Text] [Related]
6. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.
Tsigelny I; Mahata SK; Taupenot L; Preece NE; Mahata M; Khan I; Parmer RJ; O'Connor DT
Regul Pept; 1998 Oct; 77(1-3):43-53. PubMed ID: 9809795
[TBL] [Abstract][Full Text] [Related]
8. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
[TBL] [Abstract][Full Text] [Related]
9. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
10. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.
Mahata SK; Mahata M; Livsey Taylor CV; Taupenot L; Parmer RJ; O'Connor DT
Adv Exp Med Biol; 2000; 482():263-77. PubMed ID: 11192587
[No Abstract] [Full Text] [Related]
11. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.
Briolat J; Wu SD; Mahata SK; Gonthier B; Bagnard D; Chasserot-Golaz S; Helle KB; Aunis D; Metz-Boutigue MH
Cell Mol Life Sci; 2005 Feb; 62(3):377-85. PubMed ID: 15723172
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A in human hypertension. Influence of heredity.
Takiyyuddin MA; Parmer RJ; Kailasam MT; Cervenka JH; Kennedy B; Ziegler MG; Lin MC; Li J; Grim CE; Wright FA
Hypertension; 1995 Jul; 26(1):213-20. PubMed ID: 7607727
[TBL] [Abstract][Full Text] [Related]
13. The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.
Mahata SK; Mahata M; Wen G; Wong WB; Mahapatra NR; Hamilton BA; O'Connor DT
Mol Pharmacol; 2004 Nov; 66(5):1180-91. PubMed ID: 15326220
[TBL] [Abstract][Full Text] [Related]
14. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.
Mahapatra NR; O'Connor DT; Vaingankar SM; Hikim AP; Mahata M; Ray S; Staite E; Wu H; Gu Y; Dalton N; Kennedy BP; Ziegler MG; Ross J; Mahata SK
J Clin Invest; 2005 Jul; 115(7):1942-52. PubMed ID: 16007257
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel loci affecting circulating chromogranins and related peptides.
Benyamin B; Maihofer AX; Schork AJ; Hamilton BA; Rao F; Schmid-Schönbein GW; Zhang K; Mahata M; Stridsberg M; Schork NJ; Biswas N; Hook VY; Wei Z; Montgomery GW; Martin NG; Nievergelt CM; Whitfield JB; O'Connor DT
Hum Mol Genet; 2017 Jan; 26(1):233-242. PubMed ID: 28011710
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
Biswas N; Vaingankar SM; Mahata M; Das M; Gayen JR; Taupenot L; Torpey JW; O'Connor DT; Mahata SK
Endocrinology; 2008 Feb; 149(2):749-57. PubMed ID: 17991725
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A: a surprising link between granule biogenesis and hypertension.
Kim T; Loh YP
J Clin Invest; 2005 Jul; 115(7):1711-3. PubMed ID: 16007250
[TBL] [Abstract][Full Text] [Related]
18. The chromogranin-secretogranin family.
Taupenot L; Harper KL; O'Connor DT
N Engl J Med; 2003 Mar; 348(12):1134-49. PubMed ID: 12646671
[No Abstract] [Full Text] [Related]
19. Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure.
O'Connor DT; Zhu G; Rao F; Taupenot L; Fung MM; Das M; Mahata SK; Mahata M; Wang L; Zhang K; Greenwood TA; Shih PA; Cockburn MG; Ziegler MG; Stridsberg M; Martin NG; Whitfield JB
Circulation; 2008 Jul; 118(3):247-57. PubMed ID: 18591442
[TBL] [Abstract][Full Text] [Related]
20. Development of a radioimmunoassay to a fragment of vasostatin II.
Cunningham RT; Curry WJ; Johnston CF; Buchanan KD
Biochem Soc Trans; 1996 May; 24(2):304S. PubMed ID: 8736962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
